Peter S. Kim

Internal Medicine
110 Irving St NW Ste 2A38
Washington, DC 20010

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 3 publications

Analyses of Pretherapy Peripheral Immunoscore and Response to Vaccine Therapy.

Analyses of Pretherapy Peripheral Immunoscore and Response to Vaccine Therapy.

Journal: Cancer immunology research
Published: February 19, 2016

IL-15 superagonist/IL-15RαSushi-Fc fusion complex (IL-15SA/IL-15RαSu-Fc; ALT-803) markedly enhances specific subpopulations of NK and memory CD8+ T cells, and mediates potent anti-tumor activity against murine breast and colon carcinomas.

IL-15 superagonist/IL-15RαSushi-Fc fusion complex (IL-15SA/IL-15RαSu-Fc; ALT-803) markedly enhances specific subpopulations of NK and memory CD8+ T cells, and mediates potent anti-tumor activity against murine breast and colon carcinomas.

Journal: Oncotarget
Published: September 02, 2015

Pan-Bcl-2 inhibitor, GX15-070 (obatoclax), decreases human T regulatory lymphocytes while preserving effector T lymphocytes: a rationale for its use in combination immunotherapy.

Pan-Bcl-2 inhibitor, GX15-070 (obatoclax), decreases human T regulatory lymphocytes while preserving effector T lymphocytes: a rationale for its use in combination immunotherapy.

Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: February 12, 2014
Showing 1-3 of 3

Last Updated: 09/26/2026